RecruitingNCT02855476

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Studying Huntington's Disease

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University College, London
Principal Investigator: Edward J Wild, MA, MB BChir, MRCP, PhD
University College, London
Enrollment: 2500 enrolled
Eligibility: 11-75 years · All sexes
Timeline: 2017

Study locations (30)

Cenexel, Englewood, Colorado, United States
Georgetown University, Washington D.C., District of Columbia, United States
John Hopkins University, Baltimore, Maryland, United States
Wake Forest University, Winston-Salem, North Carolina, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
University of Texas Health Science Center, Houston, Texas, United States
University of British Columbia, The Centre for Huntingtons Disease, Vancouver, British Columbia, Canada
The Ottawa Hospital, Ottawa, Ontario, Canada
North York General Hospital, Toronto, Ontario, Canada
Centre for Movement Disorders, Toronto, Ontario, Canada
Centre Hospitalier Universitaire d'Angers, Angers, France
Le Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
University Hospital Ulm, Ulm, Baden-Wurttemberg, Germany
Dresden University, Dresden, Saxony, Germany
St Josef And Elisabeth Hospital, Bochum, Germany
+15 more locations on ClinicalTrials.gov

Collaborators

CHDI Foundation, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02855476 on ClinicalTrials.gov

Other trials for Huntington's Disease

Additional recruiting or active studies for the same condition.

See all trials for Huntington's Disease →

← Back to all trials